bigger in texas

Surprising new documentary explores emerging Texas mega-metro that could rival Houston

San Antonio, Austin, and the space in between could be the state's next big mega-metro. Photo by Matthew LeJune on Unsplash

It's no secret that Austin and San Antonio are becoming some of the biggest cities in Texas, and that together, they just might rival the likes of Houston and Dallas-Fort Worth one day.

A new documentary called San Antonio-Austin: The Emerging Mega-Metro takes a deep dive into the booming 80-mile region between the Central Texas cities

Produced by KLRN, San Antonio's local PBS station, the program centers on the region's growth and the challenges that arise with such rapid expansion, such as water scarcity, environmental impacts, and increasingly common transportation and traffic woes.

They're issues that Houston residents know well, as the city's population continues to explode at a staggering rate.

"We know the area between San Antonio and Austin is growing at a tremendously rapid pace, but what is really happening is the development of a mega-metro that will be one of the biggest economic powerhouses in the world," says Shari St. Clair, the documentary's executive producer, in a release.

“We delve into the questions that need to be asked right now — how do we retain quality of life as we grow? How do we build a sustainable workforce?" St. Clair continues. "And, can San Antonio and Austin truly join forces and work together to make the most of this incredible opportunity?"

The hour-long documentary is hosted by former San Antonio mayor Henry Cisneros, who also authored The Texas Triangle: An Emerging Power in the Global Economy. The special highlights several prominent Central Texas leaders, including interviews with Austin Mayor Kirk Watson, San Antonio Mayor Ron Nirenburg, U.S. Congressman Greg Casar, and more.

As Texas is also a state of committed sports fans, the idea of a mega-metro between Austin and San Antonio is additionally explored through a sports lens. The documentary interviewed legends like Nolan Ryan, Sean Elliot, and Spurs Chairman Peter J. Holt.

San Antonio-Austin: The Emerging Mega-Metro can be watched online at klrn.org.

------

This article originally ran on CultureMap.

Trending News

 
 

Promoted

A research team housed out of the newly launched Rice Biotech Launch Pad received funding to scale tech that could slash cancer deaths in half. Photo via Rice University

A research funding agency has deployed capital into a team at Rice University that's working to develop a technology that could cut cancer-related deaths in half.

Rice researchers received $45 million from the National Institutes of Health's Advanced Research Projects Agency for Health, or ARPA-H, to scale up development of a sense-and-respond implant technology. Rice bioengineer Omid Veiseh leads the team developing the technology as principal investigator.

“Instead of tethering patients to hospital beds, IV bags and external monitors, we’ll use a minimally invasive procedure to implant a small device that continuously monitors their cancer and adjusts their immunotherapy dose in real time,” he says in a news release. “This kind of ‘closed-loop therapy’ has been used for managing diabetes, where you have a glucose monitor that continuously talks to an insulin pump. But for cancer immunotherapy, it’s revolutionary.”

Joining Veiseh on the 19-person research project named THOR, which stands for “targeted hybrid oncotherapeutic regulation,” is Amir Jazaeri, co-PI and professor of gynecologic oncology at the University of Texas MD Anderson Cancer Center. The device they are developing is called HAMMR, or hybrid advanced molecular manufacturing regulator.

“Cancer cells are continually evolving and adapting to therapy. However, currently available diagnostic tools, including radiologic tests, blood assays and biopsies, provide very infrequent and limited snapshots of this dynamic process," Jazaeri adds. "As a result, today’s therapies treat cancer as if it were a static disease. We believe THOR could transform the status quo by providing real-time data from the tumor environment that can in turn guide more effective and tumor-informed novel therapies.”

With a national team of engineers, physicians, and experts across synthetic biology, materials science, immunology, oncology, and more, the team will receive its funding through the Rice Biotech Launch Pad, a newly launched initiative led by Veiseh that exists to help life-saving medical innovation scale quickly.

"Rice is proud to be the recipient of the second major funding award from the ARPA-H, a new funding agency established last year to support research that catalyzes health breakthroughs," Rice President Reginald DesRoches says. "The research Rice bioengineer Omid Veiseh is doing in leading this team is truly groundbreaking and could potentially save hundreds of thousands of lives each year. This is the type of research that makes a significant impact on the world.”

The initial focus of the technology will be on ovarian cancer, and this funding agreement includes a first-phase clinical trial of HAMMR for the treatment of recurrent ovarian cancer that's expected to take place in the fourth year of THOR’s multi-year project.

“The technology is broadly applicable for peritoneal cancers that affect the pancreas, liver, lungs and other organs,” Veiseh says. “The first clinical trial will focus on refractory recurrent ovarian cancer, and the benefit of that is that we have an ongoing trial for ovarian cancer with our encapsulated cytokine ‘drug factory’ technology. We'll be able to build on that experience. We have already demonstrated a unique model to go from concept to clinical trial within five years, and HAMMR is the next iteration of that approach.”

Trending News

 
 

Promoted